Published in Cancer Law Weekly, November 25th, 2006
A finance executive with more than 35 years of experience in healthcare, biotechnology and technology, Bratton was previously chief financial officer at Metrologic Instruments, Inc. (MTLG), a global technology company. During his tenure at Metrologic, Bratton directed the company's finance operations during a period of significant growth in sales, net income, cash flow from operations, and working capital.
"With the recent addition of two marketed oncology products, Soltamox and Caphasol, our business is poised for substantial growth...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.